Tech Company Financing Transactions
Ribbon Biolabs Funding Round
Ribbon Biolabs secured a $20 million Series A venture capital round on 2/5/2022. Investors included Hadean Ventures, Helicase Venture and IST cube Management.
Transaction Overview
Company Name
Announced On
2/5/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Hadean Ventures (Lead Investor) (Walter Stockinger)
Proceeds Purpose
The funds will be used for the commercialization of Ribbon Biolabs' DNA synthesis technology, which uses an innovative approach integrating combinatorial optimization algorithms to guide the automated enzymatic assembly of DNA.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Viehmarktgasse 1B/EG
Wien, 1030
Austria
Wien, 1030
Austria
Phone
Website
Email Address
Overview
Ribbon Biolabs mission is to serve the growing need for synthetic DNA as a fundamental component for innovation in biotechnology and biopharma. By providing our customers with rapid access to DNA molecules of sub-genomic size and in thousands of variants, we will empower them to create visionary solutions and to engineer novel products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harold de Vladar
Browse more venture capital transactions:
Prev: 2/5/2022: Loadsmart venture capital transaction
Next: 2/5/2022: Qlub venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs